Biologics and Biosimilars Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Monoclonal Antibodies, Interferon, Insulin, Vaccines, Others), By Applications (Hospital, Retail Pharmacy, Other) , and Regional Insights and Forecast to 2035

Detailed TOC of Global Biologics and Biosimilars Market 2026 by Company, Regions, Type and Application, Forecast to 2035

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologics and Biosimilars by Type
1.3.1 Overview: Global Biologics and Biosimilars Market Size by Type: 2021 Versus 2026 Versus 2035
1.3.2 Global Biologics and Biosimilars Consumption Value Market Share by Type in 2026
1.3.3 Monoclonal Antibodies
1.3.4 Interferon
1.3.5 Insulin
1.3.6 Vaccines
1.3.7 Others
1.4 Global Biologics and Biosimilars Market by Application
1.4.1 Overview: Global Biologics and Biosimilars Market Size by Application: 2021 Versus 2026 Versus 2035
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global Biologics and Biosimilars Market Size & Forecast
1.6 Global Biologics and Biosimilars Market Size and Forecast by Region
1.6.1 Global Biologics and Biosimilars Market Size by Region: 2021 VS 2026 VS 2035
1.6.2 Global Biologics and Biosimilars Market Size by Region, (2021-2035)
1.6.3 North America Biologics and Biosimilars Market Size and Prospect (2021-2035)
1.6.4 Europe Biologics and Biosimilars Market Size and Prospect (2021-2035)
1.6.5 Asia-Pacific Biologics and Biosimilars Market Size and Prospect (2021-2035)
1.6.6 South America Biologics and Biosimilars Market Size and Prospect (2021-2035)
1.6.7 Middle East & Africa Biologics and Biosimilars Market Size and Prospect (2021-2035)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologics and Biosimilars Product and Solutions
2.1.4 Roche Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biologics and Biosimilars Product and Solutions
2.2.4 Amgen Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Amgen Recent Developments and Future Plans
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biologics and Biosimilars Product and Solutions
2.3.4 AbbVie Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 AbbVie Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Biologics and Biosimilars Product and Solutions
2.4.4 Sanofi Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Biologics and Biosimilars Product and Solutions
2.5.4 Johnson & Johnson Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Biologics and Biosimilars Product and Solutions
2.6.4 Pfizer Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Novo Nordisk
2.7.1 Novo Nordisk Details
2.7.2 Novo Nordisk Major Business
2.7.3 Novo Nordisk Biologics and Biosimilars Product and Solutions
2.7.4 Novo Nordisk Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Novo Nordisk Recent Developments and Future Plans
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Biologics and Biosimilars Product and Solutions
2.8.4 Eli Lilly Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Eli Lilly Recent Developments and Future Plans
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Biologics and Biosimilars Product and Solutions
2.9.4 Novartis Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Novartis Recent Developments and Future Plans
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck Biologics and Biosimilars Product and Solutions
2.10.4 Merck Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Merck Recent Developments and Future Plans
2.11 Biogen
2.11.1 Biogen Details
2.11.2 Biogen Major Business
2.11.3 Biogen Biologics and Biosimilars Product and Solutions
2.11.4 Biogen Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Biogen Recent Developments and Future Plans
2.12 Celltrion
2.12.1 Celltrion Details
2.12.2 Celltrion Major Business
2.12.3 Celltrion Biologics and Biosimilars Product and Solutions
2.12.4 Celltrion Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Celltrion Recent Developments and Future Plans
2.13 Sobi
2.13.1 Sobi Details
2.13.2 Sobi Major Business
2.13.3 Sobi Biologics and Biosimilars Product and Solutions
2.13.4 Sobi Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Sobi Recent Developments and Future Plans
2.14 3SBIO
2.14.1 3SBIO Details
2.14.2 3SBIO Major Business
2.14.3 3SBIO Biologics and Biosimilars Product and Solutions
2.14.4 3SBIO Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 3SBIO Recent Developments and Future Plans
2.15 Changchun High Tech
2.15.1 Changchun High Tech Details
2.15.2 Changchun High Tech Major Business
2.15.3 Changchun High Tech Biologics and Biosimilars Product and Solutions
2.15.4 Changchun High Tech Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Changchun High Tech Recent Developments and Future Plans
2.16 Kanghong Pharma
2.16.1 Kanghong Pharma Details
2.16.2 Kanghong Pharma Major Business
2.16.3 Kanghong Pharma Biologics and Biosimilars Product and Solutions
2.16.4 Kanghong Pharma Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Kanghong Pharma Recent Developments and Future Plans
2.17 Innovent Biologics
2.17.1 Innovent Biologics Details
2.17.2 Innovent Biologics Major Business
2.17.3 Innovent Biologics Biologics and Biosimilars Product and Solutions
2.17.4 Innovent Biologics Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Innovent Biologics Recent Developments and Future Plans
2.18 Gan&Lee
2.18.1 Gan&Lee Details
2.18.2 Gan&Lee Major Business
2.18.3 Gan&Lee Biologics and Biosimilars Product and Solutions
2.18.4 Gan&Lee Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Gan&Lee Recent Developments and Future Plans
2.19 Tonghua Dongbao
2.19.1 Tonghua Dongbao Details
2.19.2 Tonghua Dongbao Major Business
2.19.3 Tonghua Dongbao Biologics and Biosimilars Product and Solutions
2.19.4 Tonghua Dongbao Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Tonghua Dongbao Recent Developments and Future Plans
2.20 United Laboratory
2.20.1 United Laboratory Details
2.20.2 United Laboratory Major Business
2.20.3 United Laboratory Biologics and Biosimilars Product and Solutions
2.20.4 United Laboratory Biologics and Biosimilars Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 United Laboratory Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biologics and Biosimilars Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2026)
3.2.1 Market Share of Biologics and Biosimilars by Company Revenue
3.2.2 Top 3 Biologics and Biosimilars Players Market Share in 2026
3.2.3 Top 6 Biologics and Biosimilars Players Market Share in 2026
3.3 Biologics and Biosimilars Market: Overall Company Footprint Analysis
3.3.1 Biologics and Biosimilars Market: Region Footprint
3.3.2 Biologics and Biosimilars Market: Company Product Type Footprint
3.3.3 Biologics and Biosimilars Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Biologics and Biosimilars Consumption Value and Market Share by Type (2021-2026)
4.2 Global Biologics and Biosimilars Market Forecast by Type (2026-2035)
5 Market Size Segment by Application
5.1 Global Biologics and Biosimilars Consumption Value Market Share by Application (2021-2026)
5.2 Global Biologics and Biosimilars Market Forecast by Application (2026-2035)
6 North America
6.1 North America Biologics and Biosimilars Consumption Value by Type (2021-2035)
6.2 North America Biologics and Biosimilars Market Size by Application (2021-2035)
6.3 North America Biologics and Biosimilars Market Size by Country
6.3.1 North America Biologics and Biosimilars Consumption Value by Country (2021-2035)
6.3.2 United States Biologics and Biosimilars Market Size and Forecast (2021-2035)
6.3.3 Canada Biologics and Biosimilars Market Size and Forecast (2021-2035)
6.3.4 Mexico Biologics and Biosimilars Market Size and Forecast (2021-2035)
7 Europe
7.1 Europe Biologics and Biosimilars Consumption Value by Type (2021-2035)
7.2 Europe Biologics and Biosimilars Consumption Value by Application (2021-2035)
7.3 Europe Biologics and Biosimilars Market Size by Country
7.3.1 Europe Biologics and Biosimilars Consumption Value by Country (2021-2035)
7.3.2 Germany Biologics and Biosimilars Market Size and Forecast (2021-2035)
7.3.3 France Biologics and Biosimilars Market Size and Forecast (2021-2035)
7.3.4 United Kingdom Biologics and Biosimilars Market Size and Forecast (2021-2035)
7.3.5 Russia Biologics and Biosimilars Market Size and Forecast (2021-2035)
7.3.6 Italy Biologics and Biosimilars Market Size and Forecast (2021-2035)
8 Asia-Pacific
8.1 Asia-Pacific Biologics and Biosimilars Consumption Value by Type (2021-2035)
8.2 Asia-Pacific Biologics and Biosimilars Consumption Value by Application (2021-2035)
8.3 Asia-Pacific Biologics and Biosimilars Market Size by Region
8.3.1 Asia-Pacific Biologics and Biosimilars Consumption Value by Region (2021-2035)
8.3.2 China Biologics and Biosimilars Market Size and Forecast (2021-2035)
8.3.3 Japan Biologics and Biosimilars Market Size and Forecast (2021-2035)
8.3.4 South Korea Biologics and Biosimilars Market Size and Forecast (2021-2035)
8.3.5 India Biologics and Biosimilars Market Size and Forecast (2021-2035)
8.3.6 Southeast Asia Biologics and Biosimilars Market Size and Forecast (2021-2035)
8.3.7 Australia Biologics and Biosimilars Market Size and Forecast (2021-2035)
9 South America
9.1 South America Biologics and Biosimilars Consumption Value by Type (2021-2035)
9.2 South America Biologics and Biosimilars Consumption Value by Application (2021-2035)
9.3 South America Biologics and Biosimilars Market Size by Country
9.3.1 South America Biologics and Biosimilars Consumption Value by Country (2021-2035)
9.3.2 Brazil Biologics and Biosimilars Market Size and Forecast (2021-2035)
9.3.3 Argentina Biologics and Biosimilars Market Size and Forecast (2021-2035)
10 Middle East & Africa
10.1 Middle East & Africa Biologics and Biosimilars Consumption Value by Type (2021-2035)
10.2 Middle East & Africa Biologics and Biosimilars Consumption Value by Application (2021-2035)
10.3 Middle East & Africa Biologics and Biosimilars Market Size by Country
10.3.1 Middle East & Africa Biologics and Biosimilars Consumption Value by Country (2021-2035)
10.3.2 Turkey Biologics and Biosimilars Market Size and Forecast (2021-2035)
10.3.3 Saudi Arabia Biologics and Biosimilars Market Size and Forecast (2021-2035)
10.3.4 UAE Biologics and Biosimilars Market Size and Forecast (2021-2035)
11 Market Dynamics
11.1 Biologics and Biosimilars Market Drivers
11.2 Biologics and Biosimilars Market Restraints
11.3 Biologics and Biosimilars Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Biologics and Biosimilars Industry Chain
12.2 Biologics and Biosimilars Upstream Analysis
12.3 Biologics and Biosimilars Midstream Analysis
12.4 Biologics and Biosimilars Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

;